Connect with us

Cannabis News

4 In 5 Marijuana Consumers Oppose Hemp THC Ban Trump Signed Ahead Of Rescheduling And CBD Access Order, Poll Shows

Published

on

Four out of five marijuana users say they oppose the recriminalization of hemp THC products a spending bill President Donald Trump signed into law in November, just weeks before he ordered the rescheduling of cannabis and took steps to protect access to full-spectrum CBD.

However, the current law would redefine hemp in a way that industry players believe, after Trump legitimized the sector during his first term when it was federally legalized under the 2018 Farm Bill.

While there has been some division between marijuana and hemp interests over the THC ban that goes into effect next November, an overwhelming majority of cannabis users (82 percent) said they are waiting to oppose the policy change.

That’s according to a new survey conducted by cannabis telehealth platform NuggMD, which asked marijuana users to weigh in on the law’s provisions to recriminalize hemp THC.

Only 4% of respondents said they support the ban, while 15% have no opinion on the policy.

Q: “The president recently signed legislation recriminalizing hemp-derived THC, which became legal in 2018. Do you support or oppose this policy?”
n: %
I am against politics. Hemp THC must be legal. 365 81.5%
I have no opinion on politics. 67 15.0%
I support the policy. Hemp THC should be banned. 16 3.6%

The survey interviewed 448 cannabis users living in the state’s legal markets between December 4th and 14th, with a margin of error of +/-4.63 points.

The survey came just weeks before Trump signed an executive order directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Part of that announcement also has implications for the upcoming hemp law. The president’s executive order also asked Congress consider updating the definition of hemp to ensure that full-spectrum CBD is available to patients.

Another redefinition of hemp would be part of a novel proposal allow Medicare recipients to access non-toxic CBD that would be covered under the federal health care plan.

To make this happen, the Centers for Medicare and Medicaid Services (CMS) will “enable a model that will allow certain CMS beneficiaries to benefit from receiving CBD at no cost on the basis of a physician’s recommendation,” a White House official announced in a briefing. Marihuana Moment first reported the leaked details ahead of the signing event.

“The December 18 Executive Order on Cannabis makes it clear that the White House has a real CBD agenda,” Andrew Graham, director of communications at NuggMD, told Marijuana Moment. “We looked at the popularity of recent congressional efforts to regulate hemp, because right now that policy is a big obstacle to that agenda.”

“Cannabis users are key players in this policy debate because they are directly affected by another ban on THC hemp, so their voice belongs in the conversation,” he said. “Also, there’s a practical question about the ban, because I don’t know how you would do a federal policy that bans THC but doesn’t ban CBD. Given the popularity of hemp THC products, I see this as a choice situation and I’m not going to pretend to know which side will prevail.”

Trump appeared to support a more flexible CBD policy over the summer shared a video calling for that exact reform while promoting the health benefits of cannabidiolespecially for the elderly.

Meanwhile, it would make way for the recently introduced bill in the Republican-led Congress stop implementing the hemp ban under established credit legislation.

Hemp companies and industry groups have warned about the potential ramifications of the ban, but despite states in support of cannabis rights and a recent social media post extolling the benefits of CBD, Trump signed the underlying spending measure into law without endorsing the hemp provisions.

GOP political operative Roger Stone recently said it was Trump effectively “forced” Republican lawmakers to sign the spending bill with language to ban hemp THC.

However, a White House spokesman said before signing the bill Trump was particularly supportive of the ban’s language.

The Democratic governor of Kentucky said that the hemp industry is an “important” part of the economy that deserves to be regulated at the state level—instead of being banned federally, as Congress has done—.

Additionally, a leading veterans organization is alerting Congressional leaders to the recently passed blanket ban on consumable hemp products. could inadvertently “close the door” on critical inquiry.


It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Since 2018, cannabis products have been considered legal hemp if they contain less than 0.3 percent delta-9 THC by dry weight.

The new legislation specifies that, within a year of taking effect, the weight will be applied to total THC—including delta-8 and other isomers. Also, “as tetrahydrocannabinol (or any other marketed cannabinoid) with similar effects in humans or animals (as determined by the Secretary of Health and Human Services).”

The new definition of legal hemp will also prohibit “any hemp-derived cannabinoid intermediate product marketed or sold as an end product or directly to an end consumer for personal or home use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or are unable to produce it naturally.

Legal hemp products will be limited to a total of 0.4 milligrams of total THC or any other cannabinoid with similar effects per container.

Within 90 days of the bill’s passage, the Food and Drug Administration (FDA) and other agencies must “publish a list of all cannabinoids known to the FDA to be naturally produced by a Cannabis sativa L. plant, as reflected in the peer-reviewed literature,” which include “all tetrahydrocannabinol classes known” in natural plants and “known cannabinoids.” cannabinoids that have or are marketed as having effects similar to cannabinoids of the tetrahydrocannabinol class.

The language differs slightly from provisions in legislation advanced out of the House and Senate Appropriations panels, which would have banned products with “quantifiable” amounts of THC, to be determined by the HHS secretary and the agriculture secretary.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Technical advances in cannabis curing focus on water activity and terpene stability

Published

on

By

Curing is one of those phases of cannabis production that almost everyone agrees is important, but that importance hardly translates into cannabis facilities. It’s understandable that growers want to maximize their canopy space first and foremost. After all, more flowers, more income. However, the irony is that by the time a plant reaches the curing room, most of the money has already been spent. The genetics are locked in, the lights have done their job, the rooms have been marked, the harvest has been carefully handled. And yet, quality is often validated or left behind.

Simon Knobel of Calyx Containers has spent an amazing amount of time thinking about this disintegration. The company started about 9 years ago, when Simon and his co-founder Alex were still in school and adult cannabis was becoming legal in Massachusetts. “Back then, cannabis packaging meant pill bottles, borrowed wholesale from the pharmaceutical world and reused without much thought,” explains Simon. “Our initial instinct wasn’t to do something revolutionary. It was just to build something that made sense for cannabis.”

As the company developed a range of packaging formats, the focus was on quality at the point of sale. “Scent retention, ease of use, shelf life, that was the pace of our design process. What took longer to fully register was that the degradation didn’t just happen after packaging. In many cases, it was already baked in during curing.”

Simon and Calyx did extensive market research to understand what was happening with quality degradation. “It’s good to talk not only with operators, but with consumers.” A story stuck. Simon recalls interviewing a client who was on a ski trip with his family and trying to hide the fact that he had cannabis with him. This awkwardness of smell, discretion and manipulation became a design problem. The sliding cover, integrated gasket, meant the elimination of the twisting motion that gave some users a literal pain in the wrist. But it also opened up a deeper line of research.

As Calyx began to talk more seriously with growers, a recurring question came up. Where exactly does quality start to slip? To answer this, the company partnered with the Cannabis Research Coalition and worked with Dr. Allison Justice on research based on the cure. “What we found was that it wasn’t particularly comfortable for anyone relying on legacy methods,” says Simon. “One of the biggest drivers of terpene preservation was the stability of water activity. When water activity drops below 0.55 aW, the stomata begin to collapse, then shrink, then break. At that point, the mono-terpenes escape.”

These mono-terpenes are responsible for most of the aromas associated with quality cannabis. “They are also volatile in nature. Once they’re gone, they’re gone,” highlighted Simon.

© Calyx Vessels

Basic methods and alternatives
Traditional healing methods are based on burping. Opening containers, exchanging air, manually regulating humidity. “This methodology works, but it also introduces oxygen. In addition, the plant material is also subject to mechanical stress. Both oxygen and mechanical stress accelerate degradation, thus hampering quality.”

Calyx Cure was designed as an alternative to that ritual. “Instead of active intervention, Calyx Cure uses a passive atmospheric film with selective permeation properties. The layers are designed to allow specific gases to move through the material while others are restricted. Biological curing processes continue, but without opening the container, without introducing excess oxygen and without handling the flower.”

In controlled studies, Calyx saw a 33% improvement in monoterpene profile preservation compared to traditional approaches such as turkey pouches. “Practically speaking, that first hit of aroma you get when you open a jar, driven largely by monoterpenes, is intact.”

Complicating the picture is that curing is not reversible. There is a persistent belief that if cannabis dries out too much, there are no moisture packs or other interventions that can bring it back. “Excessive drying slows down the enzymatic reactions, alters the aging process and permanently changes the composition of the terpenes. Once the quality is lost at that stage, the bottle cannot revive it,” he said.

© Calyx Vessels

Curing and speed to market
Therefore, post-harvest processes cannot be the last element of cannabis facility design. “Sometimes speed or short-term cost savings drive the decision. Cure less, move product faster and assume the container will handle the rest.” Market dynamics don’t help either. When a new market opens and the shelves are empty, speed is rewarded and cutting corners can be the difference between hitting dispensaries later.

Calyx approaches it as a manufacturing and engineering problem rather than a branding exercise. Unlike much of the packaging industry, which operates largely as a middleman, Calyx operates its own factory in Utah. “That vertical integration allows us to iterate quickly. New designs can be prototyped in 1 or 2 weeks.”

This can be a huge plus, as quality control is a hot topic in the wider world of agriculture, not just cannabis. The industry often talks about wanting nutraceutical or food standards. These industries have already solved the complexity of the supply chain. They know how to produce in one region and deliver consistently to another. Cannabis, especially if it wants to move globally, will need similar discipline.”

And as with food packaging, sustainability is part of that equation in cannabis. Calyx has extensively studied compostable and hemp-based structures. “Compostable materials struggle with terpene conservation and water activity control. If the package breathes too much, the plant pays the price.”

Instead, Calyx’s approach to sustainability is based on reducing the use of materials at the manufacturing level. “The cover molded joint is a good example,” explains Simon. “Traditional seals require cutting circular inserts from large sheets, creating huge waste. We’ve designed molds where a small amount of polymer forms the cover and joint in one plane, creating almost zero waste and a fully recyclable component.”

Healing, it seems, is not passive waiting. “It’s an active and fragile process,” says Simon. “And like most fragile things in cannabis, it benefits from being engineered rather than inherited.”

For more information:
Calyx vessels
1991 W Parkway Blvd. West Valley City, UT, 84119-2026
724-303-7481
(email protected)
calyxcontainers.com

Continue Reading

Cannabis News

Michigan Lawmakers Weigh Bill To Create Statewide Cannabis Reference Lab To Standardize Testing

Published

on

By

The facility “will allow us to inspect test results from private laboratories.”

By Katherine Dailey, Michigan Advance

Seeking to ensure stricter safety controls in Michigan’s cannabis industry, Representative Mike Mueller (R-Linden) introduced a bill to the Michigan House Rules Committee on Thursday that would establish a statewide cannabis reference laboratory to standardize testing facilities across the state.

The legislation, House Bill 4501, would establish a lab that was first funded in fiscal year 2024 appropriations and has been in the process of opening ever since.

Derek Sova, policy and legislative assistant for the Michigan Cannabis Regulatory Agency, explained to the committee that this bill was essential to ensure that laboratories had explicit authority to possess marijuana, given that it is still a federally illegal substance.

Currently, there are 17 privately owned and state-licensed cannabis testing facilities or laboratories in Michigan, Sova explained.

But some manufacturers will engage in what they call “lab shopping,” where multiple labs test their products until they get the results they want.

This laboratory, he said, “will allow us to inspect the results of private laboratory tests.”

“We are not looking to take responsibility for the test,” Sova continued. “Our goal is to make sure that the labs that do the testing themselves, that the labs get the correct test results that have to do with the testing.”

He added that the laboratory will also provide the opportunity to carry out research in-house, as opposed to asking a private laboratory to conduct state examinations.

“What this would do is to have a central state-regulated lab that would be able to take samples from every lab that tests marijuana to make sure they’re not getting bad samples or that the bigger producers are manipulating some of the findings to make sure they’re not pushing things that could go wrong with marijuana,” Mueller said.

Representatives from the Michigan Cannabis Industry Association and the state Office of Licensing and Regulatory Affairs also expressed support. invoice.

This story was first published by the Michigan Advance.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Vivent Biosignals & Green Laniel join forces to bring plant-driven agriculture to the US

Published

on

By











Vivent Biosignals and Green Laniel Consulting have announced a partnership to accelerate plant-driven irrigation and irrigation in key U.S. agricultural markets. Green Laniel Consulting is a US-focused provider of agronomic solutions led by Mauricio Manotas.

By combining Vivent’s ability to decode plant biosignals in real-time using plant biosensors, machine learning and AI with Green Laniel’s deep experience in agronomy, grower operations and US market access, the partnership allows growers to make decisions based on what really matters: how the plant itself is responding.

© Vivent Biosignals

The partnership will cover a variety of crops and production systems, initially plant-driven irrigation and greenhouses for perennial crops, including potatoes, directly guided by plant feedback.

“By combining Vivint’s plant-level intelligence with Green Laniel’s strong presence and agronomic leadership in the US, we are enabling a new generation of plant-driven farming systems. This partnership helps growers improve yields and quality while significantly increasing resource efficiency and sustainability.” says Mauricio Manotas, Green Laniel Consulting.

For more information:
Vivent Biosignals
Tel.: +41 79 5114627
Email: (email protected)
https://vivent-biosignals.com/



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media